首页> 外文期刊>Journal of managed care pharmacy : >Treatment strategies for reducing the burden of menopause-associated vasomotor symptoms.
【24h】

Treatment strategies for reducing the burden of menopause-associated vasomotor symptoms.

机译:减少绝经相关血管舒缩症状负担的治疗策略。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Vasomotor symptoms (VMS), such as hot flashes and night sweats, are the most bothersome symptoms of menopause and affect an estimated 75% of women aged over 50 years. OBJECTIVE: To discuss the burden, pathophysiology, and management of menopause-associated VMS and to evaluate pharmacologic options available for the treatment of VMS, including herbal remedies, hormone replacement therapy (HRT), and nonhormonal therapies. SUMMARY: Lifestyle changes, including regulation of core body temperature, relaxation techniques, regular physical activity, weight loss, and smoking cessation may help reduce the risk of VMS and should be implemented by all women with menopause-associated VMS. The role of herbal remedies in the treatment of VMS remains unclear, as clinical trial efficacy data are inconsistent and inconclusive. Nevertheless, soy isoflavones, red clover isoflavones, black cohosh, and vitamin E are commonly used to treat VMS and may be considered in women with mild symptoms that are not controlled by lifestyle changes alone. These herbal remedies appear to be safe when used for short durations (d 6 months). HRT, consisting of estrogen (in women without a uterus) or estrogen plus progestin (in women with a uterus) is the most widely studied and most effective treatment option for relief of menopause-associated VMS and is considered the standard of care for women with moderate-to-severe VMS. HRT should be used at the lowest effective dose and for the shortest duration possible (preferably d 5 years) in women in whom the potential benefits outweigh the potential risks. Nonhormonal therapies, such as selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, gabapentin, and clonidine, may be appropriate alternatives in women who cannot or will not use HRT for VMS relief, such as those with a history of or at risk for breast cancer. CONCLUSION: The physical and financial burden imposed by menopauseassociated VMS is immense. Optimum management of VMS includes lifestyle changes in all women and HRT in women with moderate-tosevere symptoms. Less effective herbal remedies or nonhormonal therapies may be appropriate in certain women, such as those with mild symptoms or those who cannot or will not take HRT.
机译:背景:诸如潮热和盗汗之类的血管舒缩症状(VMS)是更年期最令人讨厌的症状,估计影响了50岁以上女性的75%。目的:探讨更年期相关VMS的负担,病理生理学和管理,并评估可用于治疗VMS的药理学选择,包括草药,激素替代疗法(HRT)和非激素疗法。摘要:改变生活方式,包括调节核心体温,放松技术,定期进行体育锻炼,减轻体重和戒烟,可能有助于降低VMS的风险,所有绝经相关VMS的女性均应实施。草药疗法在VMS中的作用尚不清楚,因为临床试验疗效数据不一致且无定论。但是,大豆异黄酮,红三叶草异黄酮,黑升麻和维生素E通常用于治疗VMS,对于症状轻度不能单靠生活方式改变的女性也可以考虑使用。这些草药在短期(d 6个月)使用时似乎是安全的。由雌激素(无子宫的妇女)或雌激素加孕激素(有子宫的妇女)组成的HRT是缓解更年期相关VMS的最广泛研究和最有效的治疗选择,并且被认为是患有HRT的妇女的标准治疗方法中度到重度的VMS。对于潜在获益大于潜在风险的女性,应以最低有效剂量和尽可能短的持续时间(最好是5年)使用HRT。非激素疗法,例如选择性5-羟色胺再摄取抑制剂,5-羟色胺-去甲肾上腺素再摄取抑制剂,加巴喷丁和可乐定,对于不能使用或不使用HRT来缓解VMS的女性(例如有乳腺病史或有乳腺癌风险的女性)可能是合适的选择。癌症。结论:绝经相关的VMS给身体和经济带来巨大负担。 VMS的最佳管理包括改变所有女性的生活方式和中度至重度症状女性的HRT。对于某些女性,例如症状较轻或无法或不会接受HRT的女性,不太有效的草药或非激素疗法可能是合适的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号